Seagen Inc.
- CIK: 0001060736
- EIN: 91-1874389
- Business address: 21823 30TH DRIVE SE, SUITE, BOTHELL, Washington, 98021
Information
Mailing address
21823 30TH DRIVE SE, SUITE, BOTHELL, Washington, 98021Phone
4255274000State location
WashingtonState of incorporation
WashingtonFiscal year end
December 31SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)Filings
N/A
About Seagen Inc.
Seagen Inc. (CIK: 0001060736) is an American company incorporated in the state of Washington. Head office is located at 21823 30TH DRIVE SE, SUITE, BOTHELL, Washington, 98021. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Seagen Inc. is a public company and trade via Over-The-Counter (OTC).Old names:
- SEATTLE GENETICS INC /WA from 2000-05-Dec to 2020-08-Oct
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Epstein David R | 0001445826 | Nov-09-2022 | director, officer: Chief Executive Officer |
| SWAIN SANDRA M | 0001908755 | Nov-09-2022 | director |
| LOVE TED W | 0001188919 | May-13-2022 | director |
| BAKER JULIAN | 0001087939 | Dec-31-2020 | director, 10 percent owner |
| BAKER FELIX | 0001087940 | Dec-31-2020 | director, 10 percent owner |
| BAKER BROS. ADVISORS LP | 0001263508 | Dec-31-2020 | director, 10 percent owner |
| Baker Brothers Life Sciences LP | 0001363364 | Dec-31-2020 | director, 10 percent owner |
| 667, L.P. | 0001551139 | Dec-31-2020 | director, 10 percent owner |
| Baker Bros. Advisors (GP) LLC | 0001580575 | Dec-31-2020 | director, 10 percent owner |
| ROMP CHARLES R | 0001809717 | Apr-19-2020 | officer: EVP, Commercial |
| GRYSKA DAVID W | 0001202335 | May-20-2019 | director |
| LIPPMAN MARC E | 0001202794 | May-20-2019 | director |
| WELCH DANIEL G | 0001206199 | May-20-2019 | director |
| AKKARAJU SRINIVAS | 0001253170 | May-20-2019 | director |
| Simonian Nancy A | 0001359574 | May-20-2019 | director |
| Orwin John A | 0001477384 | May-20-2019 | director |
| Seth Alpna | 0001721020 | May-20-2019 | director |
| TAYLOR ROBIN G | 0001776737 | May-20-2019 | officer: Chief Commercial Officer |
| DANSEY ROGER D | 0001741836 | Feb-15-2019 | officer: See Remarks |
| SIMPSON TODD E | 0001216477 | Mar-20-2018 | officer: Chief Financial Officer |
| LIU JEAN I | 0001241357 | Mar-20-2018 | officer: GC & EVP, Legal Affairs |
| DRACHMAN JONATHAN G | 0001588467 | Mar-20-2018 | officer: See Remarks |
| HIMES VAUGHN B | 0001361966 | Mar-15-2018 | officer: See Remarks |
| SIEGALL CLAY B | 0001167496 | Sep-08-2016 | director, officer: President and CEO |
| Cline Darren S | 0001633639 | Aug-25-2015 | officer: EVP, Commercial |
| DOBMEIER ERIC | 0001202785 | Aug-24-2015 | officer: Chief Operating Officer |
| FBB3 LLC | 0001625395 | Dec-09-2014 | director, 10 percent owner |
| 14159, L.P. | 0001551138 | May-17-2013 | director |
| FBB2 LLC | 0001552222 | Jun-15-2012 | director, 10 percent owner |
| ROSENBERG MORRIS | 0001202786 | Apr-17-2012 | officer: EVP, Process Sciences |
| BOERNER CHRISTOPHER S. | 0001543747 | Feb-22-2012 | officer: SVP, Commercial |
| BERGER FRANKLIN M | 0001273885 | Aug-24-2010 | director |
| SEELEY BRUCE J. | 0001474462 | Oct-12-2009 | officer: EVP, Commerical |
| H&Q Employee Venture Fund 2000, L.P. | 0001420958 | May-13-2008 | 10 percent owner |
| H&Q Holdings, Inc. | 0001420959 | May-13-2008 | 10 percent owner |
| MCLAUGHLIN JOHN PETER | 0001277967 | Jun-13-2007 | director |
| Reynolds Thomas C | 0001393945 | Mar-19-2007 | officer: Chief Medical Officer |
| JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP | 0001317638 | Feb-09-2007 | 10 percent owner |
| JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P | 0001361608 | Feb-09-2007 | 10 percent owner |
| GALLEN JONATHAN | 0001069726 | Jul-07-2006 | 10 percent owner |
| TrailSmith Pamela A | 0001363253 | May-15-2006 | officer: Chief Scientific Officer |
| JPMP CAPITAL CORP | 0001330534 | Apr-06-2006 | 10 percent owner |
| Hoth Daniel Floyd JR | 0001355008 | Mar-09-2006 | director |
| JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP | 0001311205 | May-13-2005 | 10 percent owner |
| Baker Biotech Capital II (GP), LLC | 0001244386 | Apr-29-2005 | director, 10 percent owner |
| Baker Biotech Capital (GP), LLC | 0001244389 | Apr-29-2005 | director, 10 percent owner |
| Baker Bros. Capital (GP), LLC | 0001244390 | Apr-29-2005 | director, 10 percent owner |
| Baker / Tisch Capital (GP), LLC | 0001244392 | Apr-29-2005 | director, 10 percent owner |
| Baker Biotech Capital II (Z) (GP), LLC | 0001307726 | Apr-29-2005 | director, 10 percent owner |
| Baker Biotech Capital III (Z) (GP), LLC | 0001307728 | Apr-29-2005 | director, 10 percent owner |
| Baker Biotech Capital III (GP), LLC | 0001307729 | Apr-29-2005 | director, 10 percent owner |
| 14159 capital (GP), LLC | 0001317493 | Apr-29-2005 | director, 10 percent owner |
| J P MORGAN CHASE & CO | 0000019617 | May-17-2004 | 10 percent owner |
| JP MORGAN PARTNERS BHCA LP | 0001106607 | May-08-2004 | 10 percent owner |
| JP MORGAN PARTNERS GLOBAL INVESTORS LP | 0001162622 | May-08-2004 | 10 percent owner |
| J P MORGAN PARTNERS GLOBAL INVESTORS A LP | 0001167095 | May-08-2004 | 10 percent owner |
| J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP | 0001169889 | May-08-2004 | 10 percent owner |
| J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP | 0001169890 | May-08-2004 | 10 percent owner |
| JP MORGAN CHASE BANK | 0001208636 | May-08-2004 | 10 percent owner |
| DELPHI BIOINVESTMENTS VI LP | 0001241073 | May-08-2004 | 10 percent owner |
| JPMP MASTER FUND MANAGER L P | 0001243235 | May-08-2004 | 10 percent owner |
| JPMP CAPITAL CORP | 0001243236 | May-08-2004 | 10 percent owner |
| DELPHI VENTURES VI LP | 0001270723 | May-08-2004 | 10 percent owner |
| DELPHI MANAGEMENT PARTNERS VI LLC | 0001270729 | May-08-2004 | 10 percent owner |
| JPMP GLOBAL INVESTORS L P | 0001281161 | May-08-2004 | 10 percent owner |
| CASCADE INVESTMENT LLC | 0001052192 | Feb-05-2004 | other: Formerly a 10% Owner |
| CARROLL TIM | 0001202788 | Dec-05-2003 | officer: CFO |
| HELLSTROM KARL ERIK | 0001202792 | Nov-18-2003 | director |
| MCDONALD MICHAEL | 0001269773 | Nov-01-2003 | officer: Chief Medical Officer |
| WILLIAMS DOUGLAS E | 0001184847 | Sep-30-2003 | director, officer: CSO, EVP R&D |
| FELL H PERRY | 0001167449 | Sep-08-2003 | director, officer: Chairman |
| SENTER PETER | 0001202790 | Aug-21-2003 | officer: Vice President, Chemistry |
| SING AMY | 0001202789 | Aug-18-2003 | officer: Sr. Director Medical Affairs |
| SOUTHERN DOUGLAS | 0001202791 | May-15-2003 | director |
| POWELL MICHAEL | 0001202793 | May-15-2003 | director |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Seagen Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-23-302421 (34 Act) Size: 10 KB |
Dec-26-2023 | 231511269 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-059034 ( Act) Size: 48 KB |
Dec-18-2023 | |
| SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-23-126968 (34 Act) Size: 104 KB |
Dec-18-2023 | 231494819 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070886 ( Act) Size: 70 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070884 ( Act) Size: 26 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070882 ( Act) Size: 60 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070880 ( Act) Size: 17 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070879 ( Act) Size: 10 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070875 ( Act) Size: 64 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070874 ( Act) Size: 9 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070873 ( Act) Size: 30 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070868 ( Act) Size: 18 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070865 ( Act) Size: 26 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-23-020646 ( Act) Size: 6 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070863 ( Act) Size: 26 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070861 ( Act) Size: 62 KB |
Dec-15-2023 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-23-070857 ( Act) Size: 68 KB |
Dec-15-2023 | |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-295009 (33 Act) Size: 31 KB |
Dec-14-2023 | 231485709 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-295008 (33 Act) Size: 31 KB |
Dec-14-2023 | 231485707 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-295007 (33 Act) Size: 31 KB |
Dec-14-2023 | 231485704 |
Recent 20 filings. View all Seagen Inc. filings
Reviews
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Catherine
Thanks I look forward to using the product to improve my skin tone
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Frequently Asked Questions
Tags:
- Seagen Inc. overview
- Seagen Inc. job
- Seagen Inc. stock
- Seagen Inc. ownership
- Seagen Inc. CEO
- Seagen Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Lexeo Therapeutics, Inc.
Update: Nov 02, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 